DNAnexus
PrivateLast Round
Series I
Mar 8, 2022
Est. Valuation
$600M
Total Funding Raised
$472.55M
Momentum Score
25 /100
Company Overview
DNAnexus is a biomedical informatics and data management company that provides a platform for analyzing DNA-sequencing data, helping researchers in various industries to accelerate their genomics programs and effectively visualize and analyze large-scale genomic data from a unified system.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Government Contracts, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNAnexus Comps
Public and private peers based on sector, stage, and business model.
DNAnexus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series I | Mar 8, 2022 | ||||
| Series G | Jun 9, 2020 | ||||
| Series F | Feb 6, 2019 | ||||
| Series E | Jan 2, 2018 | ||||
| Series D | Apr 22, 2015 | ||||
Series C | Jan 3, 2014 |
Key People
Founding team and executive leadership
DNAnexus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Uncork Capital | Series A, Series B |
| Innovatus Capital Partners | Series I, Series F |
| GV | Series E, Series I, Series G, Series C, Series F, Series B |
| Perceptive Advisors | Series I, Series G |
| M12 - Microsoft's Venture Fund | Series E |
| Northpond Ventures | Series I, Series G |
| Foresite Capital | Series I, Series G, Series E, Series F |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2025
Dr. Oakland departs as VP and Product Lead for precision oncology.
- Aug 28, 2025
Dr. Oakland joins as VP and Product Lead.
DNAnexus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DNAnexus's valuation, stock price, and market status.
